Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach Acid

← catalyst calendar

NCT06916143 · readout ≤ 12 d

Sponsored by Eli Lilly and Company (industry) · LLY — their whole pipeline →.

Phase
Phase 1
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · None · Basic science
Enrollment
48estimated
Sites
2
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2025-04-08actualWhen the study began enrolling
Primary completionAug 2026estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completionAug 2026estimatedThe whole study's end, after follow-up
First posted2025-04-08actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-07-16actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Healthy Participants

Interventions

  • Drug: LY4100511
  • Drug: Rabeprazole

Primary outcomes

what the primary-completion date above is the date OF
Pharmacokinetic (PK): Area Under the Concentration Curve from 0 to Infinity (AUC0-∞) of LY4100511 (DC-853)
measured Predose up to 26 Days
Pharmacokinetic (PK): Maximum Concentration (Cmax) of LY4100511 (DC-853)
measured Predose up to 26 Days
Pharmacokinetic (PK): Area Under the Concentration-Time Curve from Time 0 to the Time of the Last Quantifiable Concentration (AUC0-T) of LY4100511 (DC-853)
measured Predose up to 26 Days

Permalink · LLY's whole pipeline · Catalyst calendar · Every registered study · What changed